AT17991U1 - FUNCTIONAL FOOD - Google Patents
FUNCTIONAL FOOD Download PDFInfo
- Publication number
- AT17991U1 AT17991U1 ATGM50138/2022U AT501382022U AT17991U1 AT 17991 U1 AT17991 U1 AT 17991U1 AT 501382022 U AT501382022 U AT 501382022U AT 17991 U1 AT17991 U1 AT 17991U1
- Authority
- AT
- Austria
- Prior art keywords
- food
- extract
- salacia
- salacia reticulata
- plant
- Prior art date
Links
- 235000013376 functional food Nutrition 0.000 title abstract description 11
- 241000647991 Salacia reticulata Species 0.000 claims abstract description 21
- 239000000284 extract Substances 0.000 claims abstract description 17
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 claims abstract description 11
- 108010087806 Carnosine Proteins 0.000 claims abstract description 11
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 claims abstract description 11
- 229940044199 carnosine Drugs 0.000 claims abstract description 11
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 claims abstract description 11
- 235000013305 food Nutrition 0.000 claims description 19
- 235000013570 smoothie Nutrition 0.000 claims description 4
- 235000011888 snacks Nutrition 0.000 claims description 4
- 235000009508 confectionery Nutrition 0.000 claims description 3
- 235000013618 yogurt Nutrition 0.000 claims description 3
- 229930003316 Vitamin D Natural products 0.000 claims description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 2
- 235000012970 cakes Nutrition 0.000 claims description 2
- 235000012182 cereal bars Nutrition 0.000 claims description 2
- 235000008410 fruit bars Nutrition 0.000 claims description 2
- 235000015243 ice cream Nutrition 0.000 claims description 2
- 235000019166 vitamin D Nutrition 0.000 claims description 2
- 239000011710 vitamin D Substances 0.000 claims description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 2
- 229940046008 vitamin d Drugs 0.000 claims description 2
- 235000014510 cooky Nutrition 0.000 claims 1
- 229930182490 saponin Natural products 0.000 claims 1
- 150000007949 saponins Chemical class 0.000 claims 1
- 235000017709 saponins Nutrition 0.000 claims 1
- 241000196324 Embryophyta Species 0.000 abstract description 17
- 239000000463 material Substances 0.000 description 11
- 238000002360 preparation method Methods 0.000 description 10
- 239000000419 plant extract Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 108010005094 Advanced Glycation End Products Proteins 0.000 description 5
- 208000008589 Obesity Diseases 0.000 description 5
- 241000545263 Salacia <hydroid> Species 0.000 description 5
- 206010012601 diabetes mellitus Diseases 0.000 description 5
- 235000020824 obesity Nutrition 0.000 description 5
- 235000005979 Citrus limon Nutrition 0.000 description 4
- 244000131522 Citrus pyriformis Species 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 235000003599 food sweetener Nutrition 0.000 description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 4
- 235000015205 orange juice Nutrition 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000003765 sweetening agent Substances 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 239000011668 ascorbic acid Substances 0.000 description 3
- 235000015190 carrot juice Nutrition 0.000 description 3
- 235000020235 chia seed Nutrition 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 230000013595 glycosylation Effects 0.000 description 3
- 238000006206 glycosylation reaction Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000009759 skin aging Effects 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 102000016942 Elastin Human genes 0.000 description 2
- 108010014258 Elastin Proteins 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 206010022489 Insulin Resistance Diseases 0.000 description 2
- 206010033307 Overweight Diseases 0.000 description 2
- 244000087020 Salacia prinoides Species 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 229920002549 elastin Polymers 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- AEDDIBAIWPIIBD-ZJKJAXBQSA-N mangiferin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(OC=2C(=CC(O)=C(O)C=2)C2=O)C2=C1O AEDDIBAIWPIIBD-ZJKJAXBQSA-N 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000003716 rejuvenation Effects 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- JTBGJQZJEYVBJZ-YLXTXNMFSA-N triptotriterpenic acid A Chemical compound C([C@H]1C2=CC[C@H]34)[C@](C)(C(O)=O)C[C@H](O)[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C JTBGJQZJEYVBJZ-YLXTXNMFSA-N 0.000 description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 102000011690 Adiponectin Human genes 0.000 description 1
- 108010076365 Adiponectin Proteins 0.000 description 1
- 240000004246 Agave americana Species 0.000 description 1
- 240000006162 Chenopodium quinoa Species 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- 241000134253 Lanka Species 0.000 description 1
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 1
- YWQSXCGKJDUYTL-UHFFFAOYSA-N Mangiferin Natural products CC(CCC=C(C)C)C1CC(C)C2C3CCC4C(C)(C)CCCC45CC35CCC12C YWQSXCGKJDUYTL-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 102000019280 Pancreatic lipases Human genes 0.000 description 1
- 108050006759 Pancreatic lipases Proteins 0.000 description 1
- SOWRVDSZMRPKRG-YRPOCYRVSA-N S(=O)(=O)(O[C@@H](CO)[C@@H](C[S@+]1[C@@H]([C@H]([C@@H](C1)O)O)CO)O)[O-] Chemical compound S(=O)(=O)(O[C@@H](CO)[C@@H](C[S@+]1[C@@H]([C@H]([C@@H](C1)O)O)CO)O)[O-] SOWRVDSZMRPKRG-YRPOCYRVSA-N 0.000 description 1
- 241000051611 Salacia oblonga Species 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 240000001717 Vaccinium macrocarpon Species 0.000 description 1
- 102000013127 Vimentin Human genes 0.000 description 1
- 108010065472 Vimentin Proteins 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- OMKXVFDVAGCPBS-GTEYUELZSA-N [(2s,3s,4r,5r,6s)-1-[(2r,3s,4s)-3,4-dihydroxy-2-(hydroxymethyl)thiolan-1-ium-1-yl]-2,4,5,6,7-pentahydroxyheptan-3-yl] sulfate Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](OS([O-])(=O)=O)[C@H](O)C[S+]1C[C@@H](O)[C@H](O)[C@H]1CO OMKXVFDVAGCPBS-GTEYUELZSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 108010028144 alpha-Glucosidases Proteins 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000002830 appetite depressant Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 239000002012 ayurvedic medicine Substances 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- 229940000635 beta-alanine Drugs 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000010094 cellular senescence Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 230000008576 chronic process Effects 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 235000021019 cranberries Nutrition 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 235000013367 dietary fats Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 230000008995 epigenetic change Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000020351 fruit smoothie Nutrition 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 230000004153 glucose metabolism Effects 0.000 description 1
- 150000004676 glycans Polymers 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 235000019626 lipase activity Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000002803 maceration Methods 0.000 description 1
- 229940043357 mangiferin Drugs 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 229940116369 pancreatic lipase Drugs 0.000 description 1
- 238000005325 percolation Methods 0.000 description 1
- 150000004804 polysaccharides Polymers 0.000 description 1
- 235000003784 poor nutrition Nutrition 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 235000021012 strawberries Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- JTBGJQZJEYVBJZ-UHFFFAOYSA-N triptocallic acid D Natural products C12CC=C3C4CC(C)(C(O)=O)CC(O)C4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C JTBGJQZJEYVBJZ-UHFFFAOYSA-N 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 210000005048 vimentin Anatomy 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 235000008939 whole milk Nutrition 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- H—ELECTRICITY
- H02—GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
- H02J—CIRCUIT ARRANGEMENTS OR SYSTEMS FOR SUPPLYING OR DISTRIBUTING ELECTRIC POWER; SYSTEMS FOR STORING ELECTRIC ENERGY
- H02J7/00—Circuit arrangements for charging or depolarising batteries or for supplying loads from batteries
- H02J7/0069—Charging or discharging for charge maintenance, battery initiation or rejuvenation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/37—Celastraceae (Staff-tree or Bittersweet family), e.g. tripterygium or spindletree
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R31/00—Arrangements for testing electric properties; Arrangements for locating electric faults; Arrangements for electrical testing characterised by what is being tested not provided for elsewhere
- G01R31/36—Arrangements for testing, measuring or monitoring the electrical condition of accumulators or electric batteries, e.g. capacity or state of charge [SoC]
- G01R31/367—Software therefor, e.g. for battery testing using modelling or look-up tables
-
- H—ELECTRICITY
- H02—GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
- H02J—CIRCUIT ARRANGEMENTS OR SYSTEMS FOR SUPPLYING OR DISTRIBUTING ELECTRIC POWER; SYSTEMS FOR STORING ELECTRIC ENERGY
- H02J7/00—Circuit arrangements for charging or depolarising batteries or for supplying loads from batteries
- H02J7/007—Regulation of charging or discharging current or voltage
- H02J7/00712—Regulation of charging or discharging current or voltage the cycle being controlled or terminated in response to electric parameters
- H02J7/00714—Regulation of charging or discharging current or voltage the cycle being controlled or terminated in response to electric parameters in response to battery charging or discharging current
-
- H—ELECTRICITY
- H02—GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
- H02J—CIRCUIT ARRANGEMENTS OR SYSTEMS FOR SUPPLYING OR DISTRIBUTING ELECTRIC POWER; SYSTEMS FOR STORING ELECTRIC ENERGY
- H02J7/00—Circuit arrangements for charging or depolarising batteries or for supplying loads from batteries
- H02J7/007—Regulation of charging or discharging current or voltage
- H02J7/00712—Regulation of charging or discharging current or voltage the cycle being controlled or terminated in response to electric parameters
- H02J7/007182—Regulation of charging or discharging current or voltage the cycle being controlled or terminated in response to electric parameters in response to battery voltage
-
- H—ELECTRICITY
- H02—GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
- H02J—CIRCUIT ARRANGEMENTS OR SYSTEMS FOR SUPPLYING OR DISTRIBUTING ELECTRIC POWER; SYSTEMS FOR STORING ELECTRIC ENERGY
- H02J7/00—Circuit arrangements for charging or depolarising batteries or for supplying loads from batteries
- H02J7/007—Regulation of charging or discharging current or voltage
- H02J7/00712—Regulation of charging or discharging current or voltage the cycle being controlled or terminated in response to electric parameters
- H02J7/007182—Regulation of charging or discharging current or voltage the cycle being controlled or terminated in response to electric parameters in response to battery voltage
- H02J7/007186—Regulation of charging or discharging current or voltage the cycle being controlled or terminated in response to electric parameters in response to battery voltage obtained with the battery disconnected from the charge or discharge circuit
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Power Engineering (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Die Erfindung betrifft funktionelle Lebensmittel, welche einen Extrakt einer Pflanze der Gattung Salacia reticulata und/oder Carnosin enthalten.The invention relates to functional foods which contain an extract of a plant of the genus Salacia reticulata and/or carnosine.
Description
FUNTIONELLES LEBENSMITTEL FUNTIONAL FOOD
[0001] Die vorliegende Erfindung betrifft ein funktionelles Lebensmittel zur Verbesserung der Ernährung des Menschen und trägt damit nachhaltig zur menschlichen Gesundheit bei. The present invention relates to a functional food for improving human nutrition and thus makes a lasting contribution to human health.
[0002] Übergewicht und Diabetes sind ein zunehmendes gesundheitliches Problem der Bevölkerung. Die Gründe liegen häufig bei falscher Ernährung und im Lebensstil. [0002] Obesity and diabetes are an increasing health problem among the population. The reasons often lie in poor nutrition and lifestyle.
[0003] Als Gegenmaßnahme werden zumeist Appetitzügler, Diätprodukte und Nahrungsergänzungen konsumiert, die jedoch nach Ende der Einnahme zum allgemein bekannten „JoJo-Effekt“ führen. [0003] As a countermeasure, appetite suppressants, diet products and nutritional supplements are usually consumed, which, however, lead to the well-known “yo-yo effect” after consumption has stopped.
[0004] Als natürliche Variante von Nahrungsergänzungen finden pflanzliche Heilmittel in Form von Extrakten bzw. zerkleinertem Produkt häufig Anwendung, wie z.B. in der ayurvedischen Medizin die Verwendung von Salacia Arten bei Diabetes und Fettleibigkeit. Zudem verbessert Salacia die intestinale Flora und soll wirksam gegen Rheuma, Gonorrhoe und Hautkrankheiten sein. [0004] As a natural variant of nutritional supplements, herbal remedies in the form of extracts or crushed products are often used, such as the use of Salacia species in Ayurvedic medicine for diabetes and obesity. Salacia also improves the intestinal flora and is said to be effective against rheumatism, gonorrhea and skin diseases.
[0005] Die Gattung Salacia besteht aus etwa 120 Arten, wie z.B. Salacia reticulata, Salacia oblonga, Salacia chinensis oder Salacia prinoides, und ist weit verbreitet in Sri Lanka, Indien, China, Vietnam, Indonesien und anderen asiatischen Ländern. [0005] The genus Salacia consists of about 120 species, such as Salacia reticulata, Salacia oblonga, Salacia chinensis or Salacia prinoides, and is widespread in Sri Lanka, India, China, Vietnam, Indonesia and other Asian countries.
[0006] Zahlreiche Verbindungen mit blutzuckersenkender Wirkung wurden aus Salacia Arten isoliert, wie etwa Triterpene, Kohlenwasserstoffe und Sitosterol aus Wurzeln und Rinden. In den Wurzeln der Salacia reticulata wurde Mangiferin, Kotalanol und Salacinol gefunden, welche hauptsächlich für die blutzuckersenkende Wirkung verantwortlich gemacht werden. Außerdem wurde eine Thiocyclitol-Verbindung aus dieser Pflanze mit hypoglykämischen Eigenschaften isoliert, und darüber hinaus mehrere andere Bestandteile wie Duleitol, Gerbstoffe, Kotalagenin, Maytenfolsäure und Soiguesterin (Megama et al, 2015, Review). [0006] Numerous compounds with blood sugar-lowering effects have been isolated from Salacia species, such as triterpenes, hydrocarbons and sitosterol from roots and bark. Mangiferin, kotalanol and salacinol were found in the roots of Salacia reticulata, which are mainly responsible for the blood sugar-lowering effect. In addition, a thiocyclitol compound with hypoglycemic properties was isolated from this plant, as well as several other components such as duleitol, tannins, kotalagenin, maytenfolic acid and soiguesterol (Megama et al, 2015, review).
[0007] Studien in Tiermodellen und am Menschen haben ergeben, dass Salacia reticulata den Glucose-Metabolismus verbessert, vor allem durch Hemmung von Alpha-Glucosidase, wodurch die Spaltung von Poly- und Oligosacchariden im Dünndarm in leicht absorbierbare Monosaccharide und folglich deren Absorption verzögert wird. Extrakte aus Salacia reticulata schwächen somit die postprandiale Hyperglykämie und Hypersinsulinämie ab (Megama et al, 2015, Review). [0007] Studies in animal models and humans have shown that Salacia reticulata improves glucose metabolism, primarily by inhibiting alpha-glucosidase, thereby delaying the cleavage of poly- and oligosaccharides in the small intestine into easily absorbed monosaccharides and consequently their absorption . Extracts from Salacia reticulata therefore attenuate postprandial hyperglycemia and hypersinsulinemia (Megama et al, 2015, review).
[0008] Salacia verbessert darüber hinaus die Insulin-Resistenz durch Unterdrückung der Pankreas Lipase-Aktivität, welche in der Bauchspeicheldrüse ein entscheidendes Enzym für die Verdauung von Nahrungsfett trägt. Extrakte aus Salacia reticulata schwächen somit die postprandiale Hyperlipidämie ab. Weitere Studien haben eine erhöhte Sekretion von Adiponektin ergeben, was die Insulin-Resistenz zusätzlich verbessert (Megama et al, 2015, Review). [0008] Salacia also improves insulin resistance by suppressing pancreatic lipase activity, which contains a crucial enzyme in the pancreas for the digestion of dietary fat. Extracts from Salacia reticulata thus attenuate postprandial hyperlipidemia. Further studies have shown increased secretion of adiponectin, which further improves insulin resistance (Megama et al, 2015, review).
[0009] Die Ernährung hat ebenfalls einen großen Einfluss auf die Hautalterung. Die Hautalterung ist ein komplexer, chronischer Prozess, der sich über mehrere Jahre erstreckt und bei dem externe und intrinsische Faktoren zusammenwirken. Mechanismen wie oxidativer Stress durch freie Radikale, Entzündungsprozesse, zelluläre Seneszenz und epigenetische Veränderungen sind sich nicht gegenseitig ausschließende Mechanismen, die Teil der Hautalterung sind. [0009] Diet also has a major influence on skin aging. Skin aging is a complex, chronic process that takes place over several years and in which external and intrinsic factors interact. Mechanisms such as oxidative stress caused by free radicals, inflammatory processes, cellular senescence and epigenetic changes are not mutually exclusive mechanisms that are part of skin aging.
[0010] Glykosylierung, die nicht-enzymatische Reaktion zwischen Proteinen und Zuckern, die zur Bildung und anschließenden Anhäufung von fortgeschrittenen Glykosylierungsendprodukten (AGEs) führt, wurde mit mikro- und makrovaskulären Komplikationen bei Diabetes in Verbindung gebracht. Es wurde festgestellt, dass AGEs mit extrazellulären Matrixproteinen wie Kollagen, Vimentin und Elastin verbunden sind. Es wurde berichtet, dass AGE-modifiziertes Kollagen und Elastin veränderte biomechanische Eigenschaften aufweisen, die zu Elastizitätsverlust und erhöhter Versteifung führen, und damit zu Veränderungen, die das Auftreten von Falten fördern. Die Glykosylierung verändert auch die Interaktion von Kollagen mit Zellen und beeinträchtigt deren Funktionen wie Migration, Differenzierung und Proliferation. In den letzten Jahren hat ein besseres Verständnis der Auswirkungen von AGEs auf die Struktur und Funktionalität der Haut Glycosylation, the non-enzymatic reaction between proteins and sugars that leads to the formation and subsequent accumulation of advanced glycosylation end products (AGEs), has been linked to micro- and macrovascular complications in diabetes. AGEs have been found to be associated with extracellular matrix proteins such as collagen, vimentin and elastin. AGE-modified collagen and elastin have been reported to exhibit altered biomechanical properties that result in loss of elasticity and increased stiffness, and thus changes that promote the appearance of wrinkles. Glycosylation also alters how collagen interacts with cells, affecting their functions such as migration, differentiation and proliferation. In recent years there has been a better understanding of the effects of AGEs on the structure and functionality of the skin
das Potenzial von Anti-AGE-Wirkstoffen ins Blickfeld gerückt (Narda et al., 2018). the potential of anti-AGE agents has come into focus (Narda et al., 2018).
[0011] Vor allem Carnosin wurde mit einem Schutz vor Glykosylierung bei oraler Einnahme in Verbindung gebracht. Als Anti-AGE-Wirkstoff erhöht und strafft es somit die Elastizität der Haut. Carnosin vermag die äußeren Anzeichen des Alters signifikant zu reduzieren durch Verlängerung der Lebensspanne (in Zellkulturen bis zu 300%, das entspricht 413 Tagen) und durch Verjüngung alter, seneszenter Zellen. Als Antioxidans führt es durch den ausgeprägten Zellschutz zur langsamen Alterung und wirkt somit zellverjüngend, ohne Risiko von Nebenwirkungen. [0011] Carnosine in particular has been associated with protection against glycosylation when taken orally. As an anti-AGE active ingredient, it increases and tightens the elasticity of the skin. Carnosine is able to significantly reduce the external signs of aging by extending lifespan (in cell cultures up to 300%, which corresponds to 413 days) and by rejuvenating old, senescent cells. As an antioxidant, it slows aging thanks to its pronounced cell protection and therefore has a cell-rejuvenating effect without the risk of side effects.
[0012] Carnosin zeigt ebenfalls positive Effekte auf Energie, Vitalität und die allgemeine Gesundheit des Menschen. Carnosine also shows positive effects on energy, vitality and general human health.
[0013] Carnosin ist ein Anti-Aging Peptid, welches zu 100% natürlich, vegan, glutenfrei und besteht aus körpereigen Beta-Alanin und Histidin. Es kommt besonders häufig in langlebigen Zellen, wie Muskel- und Nervenzellen, in Herzmuskel, Leber, Nieren und Gehirn vor. Der Carnosinspiegel nimmt mit zunehmendem Alter ab. Carnosine is an anti-aging peptide that is 100% natural, vegan, gluten-free and consists of the body's own beta-alanine and histidine. It is particularly common in long-lived cells, such as muscle and nerve cells, in the heart muscle, liver, kidneys and brain. Carnosine levels decrease with age.
[0014] Medagama et al. (Medagama Nutrition Journal 2015, 14(21):1-8) geben einen Überblick über die Rolle von Salacia reticulata in der Behandlung von Diabetes und Fettleibigkeit. [0014] Medagama et al. (Medagama Nutrition Journal 2015, 14(21):1-8) provide an overview of the role of Salacia reticulata in the treatment of diabetes and obesity.
[0015] Ofner et al. (Cell Cycle 2013; 12:2, 346-352) beschreiben die komplementäre Behandlung von Fettleibigkeit und Übergewicht mit Salacia reticulata und Vitamin D. [0015] Ofner et al. (Cell Cycle 2013; 12:2, 346-352) describe the complementary treatment of obesity and overweight with Salacia reticulata and vitamin D.
[0016] Narda et al. (Skin Pharmacol. Physiol. 2018, 31:324-331) beschreiben eine neue Gesichtscreme enthaltend Carnosin, welche die Bildung von AGEs in der menschlichen Haut inhibiert. [0016] Narda et al. (Skin Pharmacol. Physiol. 2018, 31:324-331) describe a new facial cream containing carnosine, which inhibits the formation of AGEs in human skin.
[0017] Derzeit werden pflanzliche Heilmittel wie Salacia reticulata Extrakt in Form von Tabletten oder Kapseln bereitgestellt, die als Ergänzung zu konventionellen Lebensmitteln eingenommen werden. [0017] Currently, herbal remedies such as Salacia reticulata extract are provided in the form of tablets or capsules that are taken as a supplement to conventional foods.
[0018] Es besteht daher ein Bedarf an neuen funktionellen Lebensmitteln, insbesondere Genussmitteln wie Süßigkeiten, die Genuss ohne Reue ermöglichen, und der Verjüngung und Langlebigkeit des Menschen dienen, ohne gesundheitsschädliche Nebenwirkungen hervorzurufen. [0018] There is therefore a need for new functional foods, in particular stimulants such as sweets, which enable enjoyment without regret and which serve to promote rejuvenation and longevity in humans without causing harmful side effects.
[0019] Wie hier verwendet, bezieht sich der Begriff "Pflanzenextrakt" auf eine Substanz die aus Pflanzenmaterial gewonnen wurde. Pflanzenextrakte können durch Behandlung eines beliebigen Pflanzenmaterials mit einem geeigneten Extraktionsmittel hergestellt werden, um einen Extrakt zu erhalten, der zumindest einige Komponenten des Pflanzenmaterials aus dem Pflanzenmaterial in wässriger Lösung oder Suspension enthält. Das Pflanzenmaterial, das mit einem Extraktionsmittel behandelt wird, um einen Pflanzenextrakt zur Verfügung zu stellen, kann jeder Teil einer Pflanze sein oder daraus gewonnen werden, zum Beispiel, der Rinde, den Wurzeln, Blättern, Blüten, Samen oder Früchten der Pflanze. [0019] As used herein, the term “plant extract” refers to a substance obtained from plant material. Plant extracts can be prepared by treating any plant material with a suitable extractant to obtain an extract containing at least some components of the plant material from the plant material in aqueous solution or suspension. The plant material that is treated with an extractant to provide a plant extract can be any part of or derived from a plant, for example, the bark, roots, leaves, flowers, seeds or fruits of the plant.
[0020] Methoden zur Herstellung von Pflanzenextrakten sind der Fachperson wohlbekannt. Beispielsweise können die Pflanzenextrakte durch Abkochen, Verdau, Perkolation, Soxlextraktation, Mazeration oder jede andere geeignete Extraktionsmethode gewonnen werden. Methods for producing plant extracts are well known to those skilled in the art. For example, the plant extracts can be obtained by boiling, digestion, percolation, Soxl extraction, maceration or any other suitable extraction method.
[0021] Bei der Herstellung von Pflanzenextrakt werden die aus dem Pflanzenmaterial extrahierten Pflanzenkomponenten zumindest teilweise in einem Extraktionsmittel, vorzugsweise ein organisches Lösungsmittel oder Wasser, löslich oder suspendierbar sein. Nach der Behandlung des Pflanzenmaterials mit dem Extraktionsmittel kann das unlösliche Pflanzenmaterial in dem Extraktionsmittel verbleiben, oder das unlösliche Pflanzenmaterial kann von dem Extraktionsmittel abgetrennt werden. Das unlösliche Pflanzenmaterial kann vom Extraktionsmittel nach einem beliebigen geeigneten Verfahren abgetrennt werden, zum Beispiel durch Dekantieren, Filtrieren oder Zentrifugieren. When producing plant extract, the plant components extracted from the plant material will be at least partially soluble or suspendable in an extractant, preferably an organic solvent or water. After treating the plant material with the extractant, the insoluble plant material may remain in the extractant or the insoluble plant material may be separated from the extractant. The insoluble plant material can be separated from the extractant by any suitable method, for example by decantation, filtration or centrifugation.
[0022] Beispielsweise wird das unlösliche Pflanzenmaterial von dem Extraktionsmittel abgetrennt, und der Pflanzenextrakt enthält keine unlöslichen Komponenten. For example, the insoluble plant material is separated from the extractant and the plant extract contains no insoluble components.
[0023] Beispielsweise liegt der Pflanzenextrakt in wässriger Lösung vor oder in einer Form bei der das Extraktionsmittel ausreichend entfernt wurde, so dass ein trockener oder nichtwässriger For example, the plant extract is in an aqueous solution or in a form in which the extractant has been sufficiently removed, so that a dry or non-aqueous
Extrakt zur Verfügung gestellt wird. Extract is provided.
[0024] Vorzugsweise wird der Pflanzenextrakt Salacia reticulata aus den Wurzeln und/oder der Stammrinde einer Pflanze der Gattung Salacia reticulata gewonnen. The plant extract Salacia reticulata is preferably obtained from the roots and/or the stem bark of a plant of the genus Salacia reticulata.
[0025] Die Neuheit dieser Erfindung liegt darin, dass Salacia reticulata Extrakt direkt in Lebensmitteln verarbeitet bzw. eingearbeitet wird, um funktionelle Lebensmittel bereitzustellen. Dem funktionellen Lebensmittel können weitere Wirkstoffe beigefügt werden, wie z.B. Zimt, Vitamine. The novelty of this invention is that Salacia reticulata extract is processed or incorporated directly into foods to provide functional foods. Other active ingredients can be added to the functional food, such as cinnamon and vitamins.
[0026] Das vorliegende Gebrauchsmuster bezieht sich auf funktionelle Lebensmittel, die durch Zusammensetzung von diversen milch(ersatz)-, schokolade-, zucker-, teig-, getreide-, fleisch-, und fischbasierten Lebensmitteln/Produkten sowie Früchten und Gemüse hergestellt werden. Funktionelle Lebensmittel können ebenfalls Getränke umfassen. Die funktionellen Lebensmittel können weitere Inhaltsstoffe wie z.B. Aromen, Süßungsmittel, Fließregulierungs- und Trennmittel enthalten. The present utility model relates to functional foods that are produced by combining various milk (substitute), chocolate, sugar, dough, grain, meat and fish-based foods/products as well as fruits and vegetables. Functional foods can also include drinks. The functional foods can contain other ingredients such as flavors, sweeteners, flow regulators and release agents.
[0027] Beispielsweise sind funktionelle Lebensmittel ausgewählt aus der Gruppe bestehend aus Joghurts, Joghurtersatzprodukten, Dips, Aufstrichen, Pasten, Snacks, Eis, Süßigkeiten, Keksen, Kuchen, Getreideriegel, Fruchtriegel, Smoothies und dergleichen. For example, functional foods are selected from the group consisting of yoghurts, yoghurt substitutes, dips, spreads, pastes, snacks, ice cream, sweets, biscuits, cakes, cereal bars, fruit bars, smoothies and the like.
[0028] Der Begriff „Snacks“, wie hier verwendet, wird als Lebensmittel verstanden, welches als Zusammensetzung von diversen verarbeiteten und unverarbeiteten Lebensmitteln/Produkten hergestellt wird. Solche Snacks können durch herkömmliche Prozesse hergestellt werden, die der Fachperson bekannt sind. [0028] The term “snacks” as used herein is understood to mean food that is produced as a composition of various processed and unprocessed foods/products. Such snacks can be prepared by conventional processes known to those skilled in the art.
[0029] Das erfindungsgemäße funktionelle Lebensmittel ist geeignet als Lebensmittel des allgemeinen Verzehrs durch einen gesunden Menschen, oder als Lebensmittel zum Verzehr durch einen Menschen, der unter Diabetes, Ubergewicht und/oder Fettleibigkeit leidet. The functional food according to the invention is suitable as a food for general consumption by a healthy person, or as a food for consumption by a person suffering from diabetes, overweight and/or obesity.
[0030] Die hier beschriebenen Beispiele sind illustrativ für die vorliegende Erfindung und nicht beabsichtigt Limitierungen derselben zu sein. AUSFÜHRUNGSBEISPIELE The examples described herein are illustrative of the present invention and are not intended to be limitations thereof. EXAMPLES OF EMBODIMENTS
BEISPIEL 1: ZUBEREITUNG EINER EISCREME EXAMPLE 1: PREPARATION OF ICE CREAM
[0031] Zubereitung umfassend: 20 g Staubzucker, 15 g Vollmilch, 15 g Mascarpone, 15 g Orangensaft, 15 g Zitronensaft, 15 g Erdbeeren, 1 Eigelb, 2 g Cointreau, 0.1 - 1 g Salacia reticulata Extrakt. Preparation comprising: 20 g powdered sugar, 15 g whole milk, 15 g mascarpone, 15 g orange juice, 15 g lemon juice, 15 g strawberries, 1 egg yolk, 2 g Cointreau, 0.1 - 1 g Salacia reticulata extract.
BEISPIEL 2: ZUBEREITUNG EINES MÜSLIRIEGELS EXAMPLE 2: PREPARATION OF A MUESLI BAR
[0032] Zubereitung umfassend: 30 g Haferflocken, 18 g Reissirup, 12 g Datteln, 10 g Agavendicksaft, 9 g Kokosnusschips, 8 g Cranberrys, 6 g Sonnenblumenöl 4 g Rosinen, 2 g Quinoa, 19 Salz und 0.1 - 1 g Salacia reticulata Extrakt. Preparation comprising: 30 g oat flakes, 18 g rice syrup, 12 g dates, 10 g agave syrup, 9 g coconut chips, 8 g cranberries, 6 g sunflower oil, 4 g raisins, 2 g quinoa, 19 salt and 0.1 - 1 g Salacia reticulata Extract.
BEISPIEL 3: ZUBEREITUNG EINES SMOOTHIES EXAMPLE 3: PREPARATION OF A SMOOTHIE
[0033] Zubereitung umfassend: 50 g Orangensaft, 30 g Karottensaft, 5 g Zitronensaft, 2 g ChiaSamen, 12 g Süßstoff, 0.9 g Ascorbinsäure und 0.1 - 1 g Salacia reticulata Extrakt. Preparation comprising: 50 g orange juice, 30 g carrot juice, 5 g lemon juice, 2 g chia seeds, 12 g sweetener, 0.9 g ascorbic acid and 0.1 - 1 g Salacia reticulata extract.
BEISPIEL 4: ZUBEREITUNG EINES SMOOTHIES EXAMPLE 4: PREPARATION OF A SMOOTHIE
[0034] Zubereitung umfassend: 50 g Orangensaft, 30 g Karottensaft, 5 g Zitronensaft, 2 g ChiaSamen, 12 g Süßstoff, 0.9 g Ascorbinsäure und 0.1 - 1 g Carnosin. Preparation comprising: 50 g orange juice, 30 g carrot juice, 5 g lemon juice, 2 g chia seeds, 12 g sweetener, 0.9 g ascorbic acid and 0.1 - 1 g carnosine.
BEISPIEL 5: ZUBEREITUNG EINES SMOOTHIES EXAMPLE 5: PREPARATION OF A SMOOTHIE
[0035] Zubereitung umfassend: 50 g Orangensaft, 30 g Karottensaft, 5 g Zitronensaft, 2 g ChiaSamen, 12 g Süßstoff, 0.9 g Ascorbinsäure, 0.1 - 1 g Salacia reticulata Extrakt und 0.1 - 19 Carnosin. Preparation comprising: 50 g orange juice, 30 g carrot juice, 5 g lemon juice, 2 g chia seeds, 12 g sweetener, 0.9 g ascorbic acid, 0.1 - 1 g Salacia reticulata extract and 0.1 - 19 carnosine.
Claims (7)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ATGM50138/2022U AT17991U1 (en) | 2022-09-08 | 2022-09-08 | FUNCTIONAL FOOD |
PCT/EP2023/073045 WO2024052120A1 (en) | 2022-09-08 | 2023-08-22 | Functional food |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ATGM50138/2022U AT17991U1 (en) | 2022-09-08 | 2022-09-08 | FUNCTIONAL FOOD |
Publications (1)
Publication Number | Publication Date |
---|---|
AT17991U1 true AT17991U1 (en) | 2023-09-15 |
Family
ID=87973353
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ATGM50138/2022U AT17991U1 (en) | 2022-09-08 | 2022-09-08 | FUNCTIONAL FOOD |
Country Status (2)
Country | Link |
---|---|
AT (1) | AT17991U1 (en) |
WO (1) | WO2024052120A1 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000086653A (en) * | 1998-09-14 | 2000-03-28 | Ranka Aayurubeedick Haabu Yakuhin Kk | Disaccharide hydrolase inhibitor |
DE60212015T2 (en) * | 2001-03-16 | 2006-11-02 | Suntory Ltd. | AUTONOMY SYSTEM CONTROL AGENTS AND HEALTHCANCES AND FOODS |
JP2019147820A (en) * | 2008-09-30 | 2019-09-05 | 小林製薬株式会社 | Metabolism activator |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008142702A1 (en) | 2007-05-23 | 2008-11-27 | Avesthagen Limited | A synergistic ayurvedic / functional food bioactive composition [cincata] |
US20140017337A1 (en) * | 2012-07-11 | 2014-01-16 | Paul Amoruso | Therapeutic methods |
CN109688832B (en) * | 2016-09-02 | 2022-03-11 | 富士胶片株式会社 | Livestock feed or livestock supplement, growth promoter for Lactobacillus bacteria, and growth promoting method for Lactobacillus bacteria |
-
2022
- 2022-09-08 AT ATGM50138/2022U patent/AT17991U1/en unknown
-
2023
- 2023-08-22 WO PCT/EP2023/073045 patent/WO2024052120A1/en unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000086653A (en) * | 1998-09-14 | 2000-03-28 | Ranka Aayurubeedick Haabu Yakuhin Kk | Disaccharide hydrolase inhibitor |
DE60212015T2 (en) * | 2001-03-16 | 2006-11-02 | Suntory Ltd. | AUTONOMY SYSTEM CONTROL AGENTS AND HEALTHCANCES AND FOODS |
JP2019147820A (en) * | 2008-09-30 | 2019-09-05 | 小林製薬株式会社 | Metabolism activator |
Non-Patent Citations (2)
Title |
---|
LIN, Y.-Y. et al. "Beneficial effects of non-herbal supplements on patients with diabetes" Diabetes & Metabolic Syndrome: Clinical Research & Reviews [online]. Juni 2022 (06.2022). Bd. 16, Nr. 6, Seiten 102510. [Zugegriffen: 9. Juni 2023]. <doi:10.1016/j.dsx.2022.102510>. Abgerufen von: <https://linkinghub.elsevier.com/retrieve/pii/S1871402122001242> * |
OFNER, M. et al. "Complementary treatment of obesity and overweight with salacia reticulata and vitamin d" International Journal for Vitamin and Nutrition Research. Internationale Zeitschrift Fur Vitamin- Und Ernahrungsforschung. Journal International De Vitaminologie Et De Nutrition. 2013 (2013). Bd. 83, Nr. 4, Seiten 216–223. [online], [Zugegriffen: 2013]. <doi:10.1024/0300-9831/a000162> * |
Also Published As
Publication number | Publication date |
---|---|
WO2024052120A1 (en) | 2024-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102076459B1 (en) | Composition containing enzyme treatmented Tenebrio molitor for muscle mass enhancement and restorative rejuvenation of recovering patients or elderly patients | |
DE69633502T2 (en) | PROCYANIDINE AS THE ACTIVE INGREDIENT AGAINST GRAVITY | |
Sharmila et al. | Cholesterol lowering activity of the aqueous fruit extract of Trichosanthes dioica Roxb. in normal and streptozotocin diabetic rats | |
JP6873517B2 (en) | Health-maintaining product composition applicable to adult women, the elderly and people in sub-health conditions | |
Ali et al. | 26 Nutritional and Medicinal Value of Date Fruit | |
US20150201661A1 (en) | Bamboo extracts, compositions and uses thereof | |
EP1784201B1 (en) | Physiologically active composition against diabetes | |
KR20150005430A (en) | Composition for relieving premenstrual syndrome and menstrual pain | |
DE69002482T2 (en) | Water soluble dietary fibers and process for their manufacture. | |
US20100247638A1 (en) | organoleptically improved dietary fiber composition and a process thereof (teestar) | |
US9132162B2 (en) | Muscadine compositions with anti-oxidant activity | |
KR101616811B1 (en) | Composition for treating diabete and diabete-induced complication containing an extract from Agrimonia pilosa | |
EP1637149A1 (en) | Dietary supplement composition for the man | |
RU2489038C1 (en) | Product for dietary, prophylactic and functional alimentation suitable for humans suffering from chronic cerebral ischemia | |
KR102078178B1 (en) | Method for manufacturing composition using wood-cultivated ginseng and Schisandra chinensis, and composition manufactured by the same | |
DE2312285A1 (en) | METHOD FOR MANUFACTURING STEROLINE-RICH PRODUCTS | |
AT17991U1 (en) | FUNCTIONAL FOOD | |
Khedr et al. | Antidiabetic and antiatherosclerotic activity of dried red radish roots (Raphanus sativus L) on hypercholesterolemic diabetic rats | |
CN107712845A (en) | Rocket ram jet extract is preparing the purposes in improving visual sensitivity health food and medicine | |
CN116019187A (en) | Anti-glycation composition of natural source, preparation method and application in oral cosmetic product | |
DE102011101102A1 (en) | Foodstuff comprises e.g. dry fruits e.g. figs, cereals e.g. oats, plant oils e.g. almond oil, natural flavorings e.g. cinnamon, vitamins, minerals, honey, fruit juices, milk products, water and components from bee products e.g. bee bread | |
DE202007007745U1 (en) | Beer containing mixed drink | |
KR20200132439A (en) | Method for Manufacturing Fermented Ginseng Tablet | |
EP1667673B1 (en) | Alpha-linolenic acid-containing vegetable oils used against diabetes | |
KR102690063B1 (en) | Composition for diminishing edema comprising herbal extracts and method for preparing thereof |